Tag : Biologic

Gastroenterology

P016 IMPROVING TUBERCULOSIS RE SCREENING IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY: A SINGLE CENTER QUALITY IMPROVEMENT INITIATIVE.

Newsemia
Biological agents have revolutionized the management of inflammatory bowel disease (IBD). There is a known increased risk of tuberculosis (TB) reactivation with biologic therapy (1)....
Latest News

2020 Biologic Drug Product Contract Manufacturer Quality Benchmarking Report – Optimize Operational and Marketing Strategies – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Biologic Drug Product Contract Manufacturer Quality Benchmarking (3rd Edition)” report has been added to ResearchAndMarkets.com’s offering. This report provides pharmaceutical companies and contract...
Latest News

Review examines the role of biologic agents in management of shoulder and elbow problems

Newsemia
The utilization of stem cell therapies for augmentation of tissue healing has far outpaced the supporting scientific and clinical data, largely due to aggressive marketing...
Latest News

First Head-to-Head Biologic Study in Ulcerative Colitis Published in The New England Journal of Medicine Highlights Benefit of Vedolizumab vs. Adalimumab

Newsemia
OSAKA, Japan–(BUSINESS WIRE)–Published in NEJM, further results from the VARSITY study which demonstrated the superiority of the gut-selective biologic vedolizumab to adalimumab Source link...
Cardiology

Patient prosthes is mismatch in stented biologic aortic valve prosthesis: 10 years' results.

Newsemia
Related Articles Patient prosthes is mismatch in stented biologic aortic valve prosthesis: 10 years’ results. Rev Port Cir Cardiotorac Vasc. 2019 Apr-Jun;26(2):101-107 Authors: Madeira M,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy